FDA Issues Class I Recall for Compounded Glutathione Peptide Injections Due to Endotoxin Contamination

The U.S. Food and Drug Administration (FDA) has announced a nationwide Class I recall, the most serious type, for compounded glutathione peptide injections. The recall was initiated due to endotoxin contamination, which poses a significant risk of serious adverse health consequences or death. Consumers are advised to check for affected product lot numbers and consult their pharmacist if they have concerns about their medication.